Special Drug Use Investigation for LAMICTAL (Long Term)
Phase of Trial: Phase IV
Latest Information Update: 09 May 2019
At a glance
- Drugs Lamotrigine (Primary)
- Indications Epilepsy
- Focus Adverse reactions
- Sponsors GlaxoSmithKline
- 08 Nov 2016 Status changed from active, no longer recruiting to completed.
- 26 Jun 2014 Planned End Date changed from 1 Dec 2015 to 1 Jul 2016 as reported by ClinicalTrials.gov record.
- 04 Jun 2013 New trial record